Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000812295-05-000042
Filing Date
2005-02-14
Accepted
2005-02-14 14:27:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 13G/A 12/31/04 OSI PHARMACEUTICALS osipharma1102005.txt SC 13G/A 6842
  Complete submission text file 0000812295-05-000042.txt   9374
Mailing Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747
Business Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Subject) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1204
Type: SC 13G/A | Act: 34 | File No.: 005-37954 | Film No.: 05607706
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 100 FILLMORE STREET 2ND FLOOR DENVER CO 80206-4923
Business Address 100 FILLMORE STREET 2ND FLOOR DENVER CO 80206-4923 3033333863
JANUS CAPITAL MANAGEMENT LLC (Filed by) CIK: 0000812295 (see all company filings)

State of Incorp.: CO | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000